Covance To Present at the UBS Global Life Sciences Conference

Tuesday, September 23, 2008 General News J E 4
PRINCETON, N.J., Sept. 22 Covance Inc. (NYSE:CVD) today announced that it will present at the UBS Global Life SciencesConference on Tuesday, September 23, 2008 at 10:00 am (ET). Investors mayaccess a live webcast of the presentation at In order toregister and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world'slargest and most comprehensive drug development services companies with annualrevenues greater than $1.5 billion, global operations in more than 20countries, and more than 9,000 employees worldwide. Information on Covance'sproducts and services, recent press releases, and SEC filings can be obtainedthrough its website at

SOURCE Covance Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Sales of Anticoagulants for the Treatment of St-El...
Baxter Initiates Phase III Trial for the Treatment...